Sivapalan, Pradeesh
Ulrik, Charlotte Suppli
Bojesen, Rasmus Dahlin
Lapperre, Therese Sophie
Eklöf, Josefin Viktoria
Håkansson, Kjell Erik Julius
Browatzki, Andrea
Tidemansen, Casper
Wilcke, Jon Torgny
Janner, Julie
Gottlieb, Vibeke
Meteran, Howraman
Porsbjerg, Celeste
Madsen, Birgitte Lindegaard
Moberg, Mia
Pedersen, Lars
Benfield, Thomas Lars
Lundgren, Jens Dilling
Knop, Filip Krag
Biering-Sørensen, Tor
Ghanizada, Muzhda
Sonne, Tine Peick
Bødtger, Uffe Christian Steinholtz
Jensen, Sidse Graff
Rasmussen, Daniel Bech
Brøndum, Eva
Tupper, Oliver Djurhuus
Sørensen, Susanne Wiemann
Alstrup, Gitte
Laursen, Christian Borbjerg
Møller, Ulla Weinrich
Sverrild, Asger
Jensen, Jens-Ulrik Stæhr http://orcid.org/0000-0003-4036-0521
Funding for this research was provided by:
Novo Nordisk Fonden (NNF20SA0062834)
Article History
Received: 7 May 2020
Accepted: 14 May 2020
First Online: 10 June 2020
Ethics approval and consent to participate
: The study has been approved by the Danish Committee on Health Research Ethics on April 3, 2020 with ref. no. H-20022574 (for protocol amendment report no. 73409). The study will ensure the protection of human participants according to the Helsinki Declaration and in accordance with Good Clinical Practice Guidelines. Participants (hospital admitted COVID-19 patients) will give written informed consent to participate. A completed patient informed consent form is required from all participants in the study and must be signed by the participant and the informing personnel.
: Not applicable.
: PS reports non-financial support from Novartis, personal fees from Boehringer Ingelheim, outside the submitted work. All the other authors declare that they have no competing interests.